Medicine
fromFortune
1 day agoAs billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial | Fortune
Life Biosciences won FDA approval for a Phase 1 trial testing partial epigenetic reprogramming gene therapy to restore vision in glaucoma and NAION patients.